Skip to content

Buyer's guide

Raising startup funding in Türkiye: which door opens at which stage

Public support, angel investment and funds are three separate doors that open in sequence. Knocking on the wrong one costs more than a rejection, because it costs time.

Written for: Founders with an idea, unsure where the capital comes from, who lose two years by getting the order wrongLast updated: 11 min read

In short

How does a startup raise funding in Türkiye?

Capital in Türkiye comes through three doors and the order matters: public support opens while an idea becomes a product, angel investment when the first customers arrive, and institutional funds once repeatable revenue is measurable. Neuros first establishes with founders which door is open; preparing for the wrong one costs far more time than a rejection does.

Where does a startup raise money at each stage?

Early-stage capital comes from three sources, and each looks for a different maturity. Skipping the sequence is not possible; founders who try spend months preparing and get the same answer: "come back when you are further along".

Which door is open at which stage
StageOpen doorWhat has to be proven
Idea and prototypePublic support programmesTechnical novelty and team capability
First customersAngel investors and networksPaying users and repeat usage
Repeatable revenueInstitutional fundsGrowth rate and unit economics
ScalingGrowth funds, abroadMarket size and defensibility

Searches this page answers

  • how do startups raise funding
  • tubitak bigg application
  • kosgeb entrepreneur support requirements
  • how to find angel investors
  • how is startup valuation calculated
  • what is a delaware flip and do i need it
  • what goes in an investor deck
  • what is technical due diligence

How do you get public innovation funding?

Private capital does not come to an idea without a product; the only source targeting that stage is public programmes. The national entrepreneurship programme targets business ideas resting on technical novelty, while the SME agency's entrepreneur programme covers the setup and operating costs of newly formed businesses. They are not alternatives — they cover different lines.

One structural change matters: support on the research council side is now framed as an investment for a small equity stake rather than a non-repayable grant. That affects your cap table before the first round, so the company's legal structure, ownership percentages and share ledger need to be in order *before* applying.

Confirm current amounts, call schedules and eligibility on the programmes' own pages; these are updated annually and the figures on intermediary consultancy sites are frequently out of date.

What do angel investors look for?

What an angel is looking for is not a deck but payment. A hundred users on a free plan is a weaker signal than five paying ones, because the first proves the product is free rather than that it works. "We have a pilot customer" gets questioned for the same reason: is the pilot paid, has it expired, did they renew?

Going through angel networks moves faster than approaching investors one by one, because networks provide screening and a standard process. Tax incentives on the individual participation side can also be decisive for the investor; that is their calculation rather than yours, but it shapes how you frame the conversation.

Should I incorporate my startup abroad?

The flip decision is about where the money comes from rather than prestige. If your investor is domestically established, a foreign structure is needless cost and extra accounting. If the funds you are targeting sit abroad, most work with standard contract structures and investing into a local limited company creates friction for them.

Timing is critical: restructuring is cheap while the company is small and the intellectual property has not dispersed, and expensive both fiscally and legally once revenue and headcount grow. Deciding before the first institutional round costs markedly less than deciding in the middle of one.

What do investors check in technical diligence?

Founders usually assume technical diligence is about whether the product is liked. What is examined is different: will the team still be able to change this product in six months? Concretely, the tests, deployment pipeline, dependency management and documentation. Their absence produces not a lower valuation but a delayed round — because an investor would rather close a risk than price it.

  • Source code and accounts belonging to the company — a server on a founder's personal account is a red flag in diligence.
  • Automated tests and a release pipeline; "we test by hand" does not scale as the team grows.
  • A personal data inventory and retention policy; in a regulated field this item alone can stop a round.
  • Third-party licence compliance — the licence of an open source component can prevent you closing your product.
  • Knowledge carried by the lead founder alone: undocumented architecture is written up as founder dependency.

How is a startup valuation decided?

At an early stage valuation is a negotiation rather than a calculation, and defending it with a formula usually backfires. The approach that works is showing which milestone you reach with how much capital and letting the valuation follow. "In 18 months our monthly recurring revenue will be at this level, and that takes this much" is more persuasive than a defence built on multiples.

One caution: a first-round valuation set too high damages both your cap table and team morale if it forces a down round next time. In early rounds the aim is not the highest number but the number that makes the next round possible.

How should founders split equity?

Splitting equally is the most common and the riskiest answer: it looks fair while nobody is thinking of leaving, and when someone does, half the company sits with a person who no longer works. What prevents that is vesting — equity earned over time, typically four years with a one-year cliff. It is one of the first documents an investor asks for, and without it a round stalls waiting on a negotiation between founders.

Will they steal my idea — can I ask for an NDA?

Institutional funds usually do not sign NDAs at an early stage; not out of bad faith but because they assess several companies in the same space. With angels it is more feasible. The practical protection is sequence rather than contract: explain the problem and the traction in the first conversation, and share technical detail once interest becomes concrete.

If we have revenue, do we need to raise at all?

Not necessarily, and not raising is not a sign of failure. Investment is taken to grow faster than revenue allows; that makes sense in markets that close quickly and is needless dilution in markets that do not. The question is not "can we raise" but: is where this capital gets us in one year enough better than where we get in two years without it?

Are the pitch deck and the data room the same thing?

They are not, and confusing them lengthens the process. The deck exists to create interest; it is short, opinionated and tells one story. The data room exists to verify it; contracts, financials, the cap table, the customer list and technical documentation sit there. Teams who start building the data room after conversations begin add weeks to the round.

Knocking on the wrong door costs more than a rejection; a rejection is an answer, wrong preparation is a lost quarter.

Sources

  1. 011512 — Girişimcilik Destek Programı (BiGG)TÜBİTAK · 2026
  2. 02Girişimci Destek ProgramıKOSGEB · 2026

Frequently asked

Questions we get asked

Some public programmes accept individual applications and require incorporation once support is granted; on the angel and fund side there is no route without a legal entity. The practical order: develop the idea and prototype individually, apply to the public programme in the form it allows, and incorporate and set the share ledger in order once private capital enters the conversation.

The count does not matter, the order does: the problem, who has it, how it is solved today, your solution, why now, what you have proven, the team, and which milestone you reach with how much capital. The "what you have proven" slide is the most skipped and the most asked about; paying customer count and repeat usage belong there.

It gets harder at an early stage but is not impossible; what decides it is who will sustain the product and how. With a product built externally the investor asks one question: are the source code, the accounts and the knowledge inside the company? If those three are in the company and documented, working with an external team is not an obstacle; if not, it is written up as founder dependency.

Usually positively: having passed an independent assessment is a validation signal, and it lets you progress without diluting. The point to watch is the cap table getting complicated where support is structured for equity; who holds what has to be clear before the first round, otherwise the round stretches while that gets tidied up.

Enough to reach the next milestone, plus three months of buffer. Asking too little forces you to reopen the round, and the gap between two rounds wears the team down; asking too much means heavy dilution for a plan not yet proven. The right question is not "how much do we need" but "how much to produce which proof".

Let's walk these steps together

We can stand alongside you while you apply any of this to your own project.